BackAbiomed Overview

Abiomed Long Term Debt

Track Abiomed's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Abiomed Long Term Debt History

Loading

Abiomed vs. peers: Long Term Debt Comparison

Loading

Abiomed Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Abiomed (ABMD) FAQ

Abiomed (ABMD) currently reports a long-term debt of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Abiomed's long-term debt history and peer comparisons.

Abiomed's long-term debt changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abiomed reported $0 in long-term debt as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abiomed, and consider following ABMD for alerts when major investors trade the stock.

Abiomed is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABMD with unrelated industries.